通过数字双胞胎进行数据增强,开发针对1型糖尿病的个性化深度学习葡萄糖预测算法,数据环境不佳
IEEE transactions on bio-medical engineering
|November 21, 2025
概括
1型糖尿病 (T1D) 的数字双胞胎生成合成数据,改进葡萄糖预测模型. 这种方法克服了数据的稀缺性,使得T1D的准确管理能够在较少的患者努力下实现.
科学领域:
- 生物医学工程 生物医学工程
- 医疗保健中的人工智能
- 内分泌学 在内分泌学.
背景情况:
- 1型糖尿病 (T1D) 的管理需要准确的葡萄糖水平预测.
- 深度学习模型看起来很有前途,但需要广泛,多样化的数据集.
- 收集全面的T1D数据集是具有挑战性和资源密集的.
研究的目的:
- 为T1D (DT-T1D) 提出使用数字双胞胎的数据增强策略.
- 为改进葡萄糖预测生成个性化的合成数据.
- 在训练深度学习模型中克服数据稀缺的局限性.
主要方法:
- 适应的ReplayBG,一个开源工具,从回顾性患者数据创建DT-T1D.
- 开发了一种两步策略:生成DT-T1D和模拟患者特定的合成数据.
- 训练有素的个性化深度网络用于使用原始和合成数据进行葡萄糖预测.
主要成果:
- 整合合成数据始终提高了模型性能.
- 用合成数据和原始数据的一小部分训练的模型与完整数据集的性能相匹配.
- 在葡萄糖水平预测方面表现出更高的准确性.
结论:
- DT-T1D驱动的数据增强有效地解决了T1D研究中的数据稀缺问题.
- 这种方法提高了深度学习模型的性能,以精确预测葡萄糖.
- 突出数字双胞胎技术的潜力,以提供强大,个性化的T1D管理工具.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Diabetes: Management and Pharmacotherapy
851
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
851
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Insulin: Dosing Regimen and Adverse Effects
663
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
663


